Nucleophilic Ring Opening of Mono-Activated Cyclopropanes with Aryl­selenolates Generated from Diselenides in the Presence of a Zn/AlCl₃ System

Abstract

An efficient one-pot synthesis of γ-arylselenenyl ketones, acids, and nitriles is presented. The method uses Zn/AlCl₃-promoted cleavage of diselenides and subsequent ring-opening of mono-activated cyclopropanes.

mono-activated cyclopropanes - ring opening - disele­nides - zinc selenolates - zinc

References and Notes

1a Liotta D. Organoselenium Chemistry   Wiley; New York: 1987. 

1b Back TG. Organoselenium Chemistry: A Practical Approach   Oxford University Press; Oxford U. K.: 1999. 

2a Mugesh G. du Mont WW. Sies H. Chem. Rev.  2001,  101:  2125 

2b Malmstrom J. Jonsson M. Cotgreave IA. Hammarstrom L. Sjodin M. Engman L. J. Am. Chem. Soc.  2001,  123:  3434 

2c Back TG. Moussa Z. J. Am. Chem. Soc.  2003,  125:  13455 

2d Lucas MA. Nagugen OTK. Schiesser CH. Zheng SL. Tetrahedron  2000,  56:  3995 

3 Monahan R. Brown D. Waykole L. Liotta D. In Organoselenium Chemistry   Liotta D. Wiley; New York: 1987. 

4a Sharpless KB. Lauer RF. J. Am. Chem. Soc.  1973,  95:  2697 

4b Aynsley EE. Greenwood NN. Leach JB. Chem. Ind. (London)  1966,  379 

4c Zhang Y. Yu Y. Lin R. Synth. Commun.  1993,  23:  189 

4d Suzuki H. Yoshinaga M. Takaoka K. Hiroi Y. Synthesis  1985,  497 

4e Liotta D. Sunay U. Santiesteban H. Markiewicz W. J. Org. Chem.  1981,  46:  2605 

4f Taboury F. Bull. Soc. Chem. Fr.  1903,  29:  761 

4g Liotta D. Markiewicz W. Santiesteban H. Tetrahedron Lett.  1977,  4365 

4h Liotta D. Santiesteban H. Tetrahedron Lett.  1977,  4369 

5a Danishefsky S. Acc. Chem. Res.  1979,  12:  66 

5b Danishefsky S. Mckee R. Singh RK. J. Am. Chem. Soc.  1977,  99:  4783 

6a Wrobel T. Takahashi K. Honkan V. Lannoye G. Cook TM. Bertz SH. J. Org. Chem.  1983,  48:  139 

6b Zutterman E. De Wilde H. Mijngheer R. De Clercq P. Vandewalle H. Tetrahedron  1979,  35:  2389 

7a Taber DF. J. Am. Chem. Soc.  1977,  99:  3513 

7b Caputo R. Ferreri C. Palumbo G. Tetrahedron Lett.  1984,  25:  577 

7c Kondo K. Umemoto T. Takahatake Y. Tunemoto D. Tetrahedron Lett.  1977,  23:  113 

8 Meinwald J. Crandall K. J. Am. Chem. Soc.  1966,  88:  1292 

9 Smith AB. Scarborough RM. Tetrahedron Lett.  1978,  1649 

10 Scarborough RM. Toder BH. Smith AB. J. Am. Chem. Soc.  1980,  102:  3904 

11a Nazari M. Movassagh B. Tetrahedron Lett.  2009,  50:  1453 

11b Nazari M. Movassagh B. Tetrahedron Lett.  2009,  50:  438 

11c Movassagh B. Tatar A. Synlett  2007,  1954 

11d Movassagh B. Mirshojaei F. Monatsh. Chem.  2003,  134:  831 

11e Movassagh B. Shamsipoor M. Synlett  2005,  1316 

11f Movassagh B. Fazeli A. Z. Naturforsch., B  2006,  61:  194 

11g Movassagh B. Shamsipoor M. Joshaghani M. J. Chem. Res., Synop.  2004,  148 

11h Movassagh B. Shamsipoor M. Synlett  2005,  127 

11i Movassagh B. Fazeli A. Monatsh. Chem.  2007,  138:  863 

12

General Procedure: A mixture of diaryl diselenide (0.5 mmol) and zinc powder (3.0 mmol) in anhydrous MeCN (15 mL), was stirred at 70 ˚C. After 15 min, anhydrous AlCl₃ (3.0 mmol in 2 mL anhydrous MeCN) was added cautiously. The mixture was stirred for 1 h at 70 ˚C, until the yellow solution turned colorless. The mono-activated cyclopropane (1.1 mmol) was then added to the solution and the mixture was stirred at 70 ˚C for the period of time specified in Table  [¹] . The progress of reaction was monitored with TLC. After the reaction was complete, the solution was filtered and the solvent was evaporated. Aqueous HCl (10%) was added to the crude product and the mixture was extracted with EtOAc (2 × 30 mL). The combined organic layers were dried over anhydrous Na₂SO₄, filtered, and the solvent was removed under reduced pressure. Purification by preparative TLC (silica gel; n-hexane-EtOAc, 3:1) gave the corres-ponding arylselenenyl-functionalized ring-opened product. All novel compounds were characterized by ^¹H and ^¹³C NMR, IR, mass spectroscopy, and elemental analysis. Compound 4e: IR (neat): 1723, 2725, 2825 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 2.06 (quin, J = 6.9 Hz, 2 H), 2.64 (t, J = 6.9 Hz, 2 H), 2.98 (t, J = 7.0 Hz, 2 H), 7.23-7.61 (m, 5 H), 9.80 (s, 1 H) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 22.9, 27.5, 29.3, 127.5, 129.4, 129.6, 132.7, 201.8 ppm. LRMS: m/z (%) = 227 (25) [M + 2]⁺, 225 (12) [M]⁺, 185 (45), 183 (22), 171 (32), 169 (15), 157 (78), 155 (42), 123 (53), 105 (31), 91 (100), 77 (78), 71 (58), 55 (45), 41 (49). Anal. Calcd for C₁₀H₁₂OSe: C, 52.87; H, 5.32. Found: C, 52.95; H, 5.35. Compound 4f: IR (neat): 1714 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 1.96 (quin, J = 7.1 Hz, 2 H), 2.13 (s, 3 H), 2.59 (t, J = 7.0 Hz, 2 H), 2.91 (t, J = 7.2 Hz, 2 H), 7.24 (d, J = 8.5 Hz, 2 H), 7.43 (d, J = 8.5 Hz, 2 H) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 23.9, 27.5, 30.0, 42.9, 128.2, 129.2, 133.1, 134.0, 207.7 ppm. LRMS: m/z (%) = 278 (7) [M + 4]⁺, 276 (15) [M + 2]⁺, 274 (7) [M]⁺, 191 (4), 156 (3), 125 (3), 85 (100), 43 (86). Anal. Calcd for C₁₁H₁₃ClOSe: C, 47.93; H, 4.75. Found: C, 47.83; H, 4.39. Compound 4g: mp 100-101 ˚C. IR (KBr disk): 1709, 2450-3500 cm^-¹. ^¹H NMR (300 MHz, CDCl₃): δ = 1.99 (quin, J = 7.2 Hz, 2 H), 2.51 (t, J = 7.2 Hz, 2 H), 2.94 (t, J = 7.3 Hz, 2 H), 7.24 (d, J = 8.5 Hz, 2 H), 7.43 (d, J = 8.5 Hz, 2 H), 11.50 (br s, 1 H) ppm. ^¹³C NMR (75 MHz, CDCl₃): δ = 24.8, 27.1, 33.5, 127.7, 129.3, 133.3, 134.2, 179.3 ppm. LRMS:
m/z (%) = 280 (10) [M + 4]⁺, 278 (24) [M + 2]⁺, 276 (11) [M]⁺, 192 (21), 156 (16), 112 (24), 87 (100), 43 (44). Anal. Calcd for C₁₀H₁₁ClO₂Se: C, 43.27; H, 3.99. Found: C, 43.16; H, 3.83. Compound 4h: IR (neat): 2246 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 2.00 (quin, J = 7.0 Hz, 2 H), 2.51 (t, J = 7.0 Hz, 2 H), 2.99 (t, J = 7.1 Hz, 2 H), 7.27 (d, J = 8.5 Hz, 2 H), 7.45 (d, J = 8.5 Hz, 2 H) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 17.1, 25.7, 26.4, 118.8, 127.0, 129.5, 133.9, 134.7 ppm. LRMS: m/z (%) = 261 (50) [M + 4]⁺, 259 (100) [M + 2]⁺, 257 (52) [M]⁺, 191 (14), 156 (14), 112 (11), 68 (14), 41 (27). Anal. Calcd for C₁₀H₁₀ClNSe: C, 46.44; H, 3.90; N, 5.42. Found: C, 46.73; H, 4.15; N, 5.58. Compound 4i: IR (neat): 1714 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 1.96 (quin, J = 7.1 Hz, 2 H), 2.13 (s, 3 H), 2.59 (t, J = 7.1 Hz, 2 H), 2.99 (t, J = 7.1 Hz, 2 H), 7.40 (t, J = 7.7 Hz, 1 H), 7.50-7.62 (m, 2 H), 7.78-7.89 (m, 3 H), 8.40 (d, J = 8.4 Hz, 1 H) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 24.0, 27.5, 29.7, 43.1, 125.8, 126.2, 126.6, 127.5, 128.3, 128.7, 129.2, 132.3, 134.1, 134.3, 207.9 ppm. LRMS: m/z (%) = 292 (17) [M + 2]⁺, 290 (10) [M]⁺, 207 (6), 165 (6), 141 (6), 128 (15), 115 (17), 85 (100), 43 (99). Anal. Calcd for C₁₅H₁₆OSe: C, 61.86; H, 5.54. Found: C, 62.17; H, 5.76. Compound 4j: IR (neat): 1708, 2400-3500 cm^-¹. ^¹H NMR (500 MHz, CDCl₃): δ = 2.01 (quin, J = 7.2 Hz, 2 H), 2.53 (t, J = 7.3 Hz, 2 H), 3.02 (t, J = 7.2 Hz, 2 H), 7.41 (t, J = 7.7 Hz, 1 H), 7.51-7.63 (m, 2 H), 7.80-7.90 (m, 3 H), 8.45 (d, J = 8.4 Hz, 1 H), 11.41 (br s, 1 H) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 25.0, 27.1, 33.8, 125.8, 126.3, 126.7, 127.6, 128.5, 128.7, 129.1, 132.5, 134.1, 134.4, 179.3 ppm. LRMS: m/z (%) = 294 (87) [M + 2]⁺, 292 (47) [M]⁺, 208 (38), 141 (14), 128 (100), 115 (65), 87 (67), 43 (24). Anal. Calcd for C₁₄H₁₄O₂Se: C, 57.35; H, 4.81. Found: C, 56.99; H, 5.03.